Induction of remission in patients with mild to moderate active Crohn's disease affecting the ileum and/or the ascending colon Induction of remission in patients with active microscopic colitis in adults aged ≥ 18 years.
- Crohn's disease Induction of remission in patients with mild to moderate active Crohn's disease affecting the ileum and/or the ascending colon - Microscopic colitis - Autoimmune hepatitis
For the treatment of acute episodes and the maintenance of remission of mild to moderate ulcerative colitis.
For the treatment of pancreatic exocrine insufficiency.
Nexium oral suspension is primarily indicated for: Paediatric population Children 1-11 years old Gastroesophageal Reflux Disease (GERD) - treatment of endoscopically proven erosive reflux esophagitis - symptomatic treatment of gastroesophageal reflux disease (GERD) Children over 4 years of age In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori . Adults and adolescents from the age of 12 years For indications in patients from the age of 12 years reference is made to the Nexium gastro-resistant tablet SmPC. Nexium oral suspension may also be used by patients having difficulty swallowing dispersed Nexium gastro-resistant tablets.
Esomeprazole 20 mg gastro-resistant tablets: Esomeprazole 20 mg gastro-resistant tablets are indicated for: Adults Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (GERD) In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and - healing of Helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers. Patients requiring continued NSAID therapy Healing of gastric ulcers associated with NSAID therapy. Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. Treatment of Zollinger Ellison Syndrome Adolescents from the age of 12 years Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (GERD) In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori Esomeprazole 40 mg gastro-resistant tablets : Esomeprazole 40 mg gastro-resistant tablets are indicated for: Adults Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis. Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. Treatment of Zollinger Ellison Syndrome Adolescents from the age of 12 years Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis
Cefalexin is a semisynthetic cephalosporin antibiotic for oral administration. Cefalexin is indicated in the treatment of the following infections due to susceptible micro-organisms: Respiratory tract infections Otitis media Skin and soft tissue infections Bone and joint infections Genito-urinary tract infections, including acute prostatitis Dental infections